Like any other medical specialty, family medicine needs to engage in research in order to expand its evidence base. With drug companies funding the bulk of clinical research,1 it is natural for family physicians to turn to the pharmaceutical industry for funding—natural, but a serious mistake. There are 3 big reasons for look-ing elsewhere for research dollars: drug companies have a narrow range of interests; many of the postapproval studies that they fund are “seeding trials”; and the results of industry-funded research are often biased. Range of interests For sound economic reasons, companies are interested in funding research that will increase the sales of their products. At the same time, many of the problems that family medicine deals...
The relationship between the drug industry and healthcare professionals has always been one filled w...
R&D of new drugs is driven by pharmaceutical companies that invest considerable amounts of money for...
Pharmaceutical companies share the goal of patient benefit with healthcare professionals. However, t...
When the new field of family medicine research began a half century ago, multiple individuals and or...
Although there is general agreement that family medicine has a lot to offer to the health care syste...
medical journals, pointed an accusing finger at the increasing pressures coming from the pharmaceuti...
Pharmaceutical and device manufacturers fund more than half of the medical research in the U.S. Rese...
“The ongoing development of the specialty and its need to contribute more substantially to the body ...
One must always be aware that external influences may affect the interpretation of study results, t...
Funding for clinical research has changed dramat-ically over the past 2 or 3 decades. Before 1970, f...
The field of reproductive medicine is known for its innovations, and where there is innovation there...
Bolon and Phillips and an accompanying editorial by Ferrer regarding the availability of research tr...
p. 551-560AIM: Many questions of relevance to patients/society are not answered by industry-sponsore...
The future of family medicine depends on a thriv-ing research enterprise that requires a clear visio...
Academics are debating whether industry funding influ-ences research findings and conclusions.1–7 Th...
The relationship between the drug industry and healthcare professionals has always been one filled w...
R&D of new drugs is driven by pharmaceutical companies that invest considerable amounts of money for...
Pharmaceutical companies share the goal of patient benefit with healthcare professionals. However, t...
When the new field of family medicine research began a half century ago, multiple individuals and or...
Although there is general agreement that family medicine has a lot to offer to the health care syste...
medical journals, pointed an accusing finger at the increasing pressures coming from the pharmaceuti...
Pharmaceutical and device manufacturers fund more than half of the medical research in the U.S. Rese...
“The ongoing development of the specialty and its need to contribute more substantially to the body ...
One must always be aware that external influences may affect the interpretation of study results, t...
Funding for clinical research has changed dramat-ically over the past 2 or 3 decades. Before 1970, f...
The field of reproductive medicine is known for its innovations, and where there is innovation there...
Bolon and Phillips and an accompanying editorial by Ferrer regarding the availability of research tr...
p. 551-560AIM: Many questions of relevance to patients/society are not answered by industry-sponsore...
The future of family medicine depends on a thriv-ing research enterprise that requires a clear visio...
Academics are debating whether industry funding influ-ences research findings and conclusions.1–7 Th...
The relationship between the drug industry and healthcare professionals has always been one filled w...
R&D of new drugs is driven by pharmaceutical companies that invest considerable amounts of money for...
Pharmaceutical companies share the goal of patient benefit with healthcare professionals. However, t...